Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.

Alimentary Pharmacology & Therapeutics
Ashwin N AnanthakrishnanS Murphy

Abstract

The increasing incidence of Clostridium difficile (C. difficile) infection (CDI) among patients with inflammatory bowel disease is well recognised. However, most studies have focused on demonstrating that CDI is associated with adverse outcomes in IBD patients. Few have attempted to identify predictors of severe outcomes associated with CDI among IBD patients. To identify clinical and laboratory factors that predict severe outcomes associated with CDI in IBD patients. From a multi-institution EMR database, we identified all hospitalised patients with at least one diagnosis code for C. difficile from among those with a diagnosis of Crohn's disease or ulcerative colitis. Our primary outcome was time to total colectomy or death with follow-up censored at 180 days after CDI. Cox proportional hazards models were used to identify predictors of the primary outcome from among demographic, disease-related, laboratory and medication variables. A total of 294 patients with CDI-IBD were included in our study. Of these, 58 patients (20%) met our primary outcome (45 deaths, 13 colectomy) at a median of 31 days. On multivariate analysis, serum albumin <3 g/dL (HR 5.75, 95% CI 1.34-24.56), haemoglobin below 9 g/dL (HR 5.29, 95% CI 1.58-17.69) ...Continue Reading

References

Jan 6, 1993·JAMA : the Journal of the American Medical Association·R Fekety, A B Shah
Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
Jun 6, 2002·Alimentary Pharmacology & Therapeutics·M DapernoA Pera
Oct 29, 1955·British Medical Journal·S C TRUELOVE, L J WITTS
Sep 1, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jacques PépinDaniel Chouinard
Oct 16, 2004·Journal of Gastroenterology and Hepatology·Sanjay KumarGourdas Choudhuri
Aug 27, 2005·The Lancet Infectious Diseases·Saima AslamDaniel M Musher
Dec 21, 2006·Emerging Infectious Diseases·Erik R DubberkeVictoria J Fraser
Mar 21, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Joseph F RodemannChristian D Stone
Mar 21, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Mazen IssaDavid G Binion
Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fred A ZarMelinda B Davis
Jul 20, 2007·Alimentary Pharmacology & Therapeutics·C W LeesUNKNOWN Scottish Society of Gastroenterology Infliximab Group
Feb 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John G Bartlett
Dec 4, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Erik R Dubberke, Albert I Wertheimer
Dec 17, 2008·Alimentary Pharmacology & Therapeutics·D Gujja, F K Friedenberg
Feb 5, 2009·JAMA : the Journal of the American Medical Association·Ciarán P Kelly
Mar 4, 2009·Digestive Diseases and Sciences·Daniela JodorkovskyMaria T Abreu
Jul 18, 2009·International Journal of Antimicrobial Agents·Hanna Pituch
Jun 16, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shomron Ben-HorinUNKNOWN European Crohn's and Colitis Organization (ECCO)
Jun 17, 2009·Nature Reviews. Microbiology·Maja RupnikDale N Gerding
Nov 17, 2009·Gastroenterology Clinics of North America·Ashwin N AnanthakrishnanDavid G Binion
Jan 22, 2010·Inflammatory Bowel Diseases·Ashwin N AnanthakrishnanKia Saeian
Mar 24, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stuart H CohenUNKNOWN Infectious Diseases Society of America
Nov 26, 2010·Current Opinion in Gastroenterology·Caoilfhionn O'Donoghue, Lorraine Kyne
Dec 2, 2010·Nature Reviews. Gastroenterology & Hepatology·Ashwin N Ananthakrishnan
Jan 5, 2011·Alimentary Pharmacology & Therapeutics·J R GoodhandD S Rampton
Feb 4, 2011·The New England Journal of Medicine·Thomas J LouieUNKNOWN OPT-80-003 Clinical Study Group
Aug 19, 2011·The Journal of Hospital Infection·O A LungulescuJ G Stratidis

❮ Previous
Next ❯

Citations

May 2, 2012·Nature Reviews. Gastroenterology & Hepatology·Sahil Khanna, Darrell S Pardi
Jul 19, 2013·Inflammatory Bowel Diseases·Seymour KatzDarrell S Pardi
Dec 7, 2013·World Journal of Gastroenterology : WJG·Nagham KhanaferPhilippe Vanhems
May 20, 2014·Current Gastroenterology Reports·Jana G Hashash, David G Binion
Sep 10, 2013·Infectious Disease Clinics of North America·Dallas G Hoover, Alexander Rodriguez-Palacios
May 25, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Raina ShivashankarDarrell S Pardi
Jul 16, 2013·Alimentary Pharmacology & Therapeutics·A N AnanthakrishnanR J Xavier
Oct 26, 2012·Alimentary Pharmacology & Therapeutics·E MattilaV-J Anttila
Aug 1, 2015·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Jiang-Chen PengZhi-Hua Ran
Apr 14, 2015·Scandinavian Journal of Gastroenterology·Andrew TinsleyThomas A Ullman
Apr 29, 2015·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Andreas M KaiserUNKNOWN CME Committee of the SSAT
Dec 17, 2014·Digestive Diseases and Sciences·Dennis L ShungJason K Hou
Apr 19, 2016·Expert Review of Gastroenterology & Hepatology·Osman Ahmed, Geoffrey C Nguyen
May 4, 2016·Current Infectious Disease Reports·Nancy Fu, Titus Wong
Aug 16, 2016·Infectious Diseases and Therapy·Alberto Cózar-LlistóJavier Cobo
Sep 21, 2013·Inflammatory Bowel Diseases·Maneesh DaveEdward V Loftus
Sep 1, 2017·Inflammatory Bowel Diseases·Prashant MudireddyGary R Lichtenstein
Sep 8, 2016·World Journal of Gastrointestinal Pharmacology and Therapeutics·Gianluca AndrisaniLuisa Guidi
Jun 26, 2013·Antimicrobial Agents and Chemotherapy·Hayden T SchwenkThomas J Sandora
Oct 13, 2018·Inflammatory Bowel Diseases·Dana J LukinUNKNOWN IBD-ReMEdY Study (Research, Mentoring, Education New York)
Sep 11, 2014·World Journal of Gastroenterology : WJG·Anca TrifanCamelia Cojocariu
Jan 14, 2018·Journal of Digestive Diseases·UNKNOWN Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association
Jan 14, 2020·International Journal of Colorectal Disease·Haggai Bar-YosephMatti Waterman
Mar 20, 2013·Journal of Clinical Gastroenterology·Sheela S Reddy, Lawrence J Brandt
May 21, 2019·Therapeutic Advances in Gastroenterology·Srishti Saha, Sahil Khanna
Feb 18, 2017·Clinical Journal of Gastroenterology·Ying M Tang, Christian D Stone
Mar 5, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Abdulmajeed A AlbarrakVeysel Tahan
Oct 17, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·George KhoudariMiguel Regueiro
Apr 1, 2021·Therapeutic Advances in Gastroenterology·Elida VothSahil Khanna
Mar 4, 2021·Current Opinion in Gastroenterology·Rahul S Dalal, Jessica R Allegretti
May 19, 2021·The American Journal of Gastroenterology·Colleen R KellyNeil H Stollman
Jun 10, 2021·Therapeutic Advances in Gastroenterology·Kanika SehgalSahil Khanna

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Alimentary Pharmacology & Therapeutics
Ashwin N AnanthakrishnanR J Xavier
Expert Review of Gastroenterology & Hepatology
Ashwin N Ananthakrishnan, David G Binion
© 2022 Meta ULC. All rights reserved